https://ogma.newcastle.edu.au/vital/access/ /manager/Index ${session.getAttribute("locale")} 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:10824 Wed 11 Apr 2018 16:58:46 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:34397 in vitro. Notably, only the first eluted MP fraction bound HK₂ cells indicating a possible association between MP size and cell‑targeting properties.]]> Tue 03 Sep 2019 18:26:10 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:12418 Thu 30 Mar 2023 15:53:20 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:17046 Sat 24 Mar 2018 08:05:06 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:3721 Sat 24 Mar 2018 07:20:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47510 Mon 23 Jan 2023 12:08:39 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:47375 5 nanoparticles per cell. Despite their high concentrations, the nanoparticles were remarkably well tolerated by the cells, demonstrating their superb potential for in vivo cellular uptake. This study advances previous research on plasma-polymerized nanoparticles, introducing a low-waste synthesis method that achieves higher yields. This sustainable technology has important implications for the production of multifunctional nanoparticles for drug delivery, tumor targeting, and medical imaging.]]> Mon 19 Jun 2023 14:59:08 AEST ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:42292 Fri 19 Aug 2022 14:58:19 AEST ]]>